Studies on the chromosomes of murine Dalton's lymphoma cells and the effect of cisplatin on chromosomes of these cells and bone marrow cells in vivo

Cytologia

Volumn 63, Issue 4, 1998, Pages 405-413

  Prasad, Surya B ^a   Giri, Anirudha ^a   Khynriam, Dimos ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

MURINAE;

EID: 0032435699     PISSN: 00114545     EISSN: None     Source Type: Journal    
DOI: 10.1508/cytologia.63.405     Document Type: Article

References (41)

1. Arrick, B. A. and Nathan, C. F. 1984. Glutathione metabolism as a determinant of therapeutic efficacy' a review. Cancer Res. 44, 4224-4232.
2. Bocian, E. M. Laverick, M. and Nias, A. H W. 1983. Sister chromatid exchanges induced by two radiosensizing platinum compounds cis-dichlorobis-isopropylamine-trans-dihydroxyplatinum (IV) (CHIP) and cis-platin metromdazole C 2 (FLAP) in CHO cells in vitro Br. J Cancer 48: 803-807.
3. Bradley, L. J N. Yarema, K. J., Lippard, S. J. and Essigmann, J. M. 1993. Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum. Biochemistry 32: 982-988.
4. Carter, S. K. 1984. Cisplatin-past, present and future. In: Platinum Coordination Complexes in Cancer Chemotherapy (Eds. Hacker, M. P., Douple, E. B. and Krakoff, I. H.), Martinus Nijhpff Publishing, Boston, pp. 359-376.
5. Chakrabarti, S . Chakrabarti, A. and Pal, A. K. 1984. Chromosomal analysis of Dalton's lymphoma adapted to the Swiss mouse: clonal evaluation and C-heterochromatin distribution. Cancer Genet. Cytogenet. 11: 417-423.
6. Chu, G. 1994. Cellular responses to cisplatin. J. Biol. Chem. 269: 787-790.
7. Corden, B. J 1987. Reaction of platinum (II) antitumor agents with sulfhydral compounds and the implications for nephrotoxicity inorg, Chim. Acta 137: 125-130.
8. Cross, H. J. Tilby, M., Chipman, J. K., Ferry, D. R. and Gescher, A. 1996. Effect of quercetin on the genotoxic potential of cisplatin. Int. J. Cancer 66: 404-408.
9. Dabholkar, M and Reed, E. 1996. Cisplatin. In: Pinedo, H. M., Longo, D. L. and Chabner, B. A. (eds.). Cancer Chemotherapy and Biological Response Modifiers Annual 16, Elsevier Science Publishers, Netherlands, pp. 88-110.
10. Dijt, F. J., Fichtinger-Schepman, A. M. J., Berends, F. and Reedijk, J. 1988. Formation and repair of cisplann-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts. Cancer Res. 48: 6058-6062.
11. Dowjat, K. and Kawiak, J. 1979. Karyotype analysis of two LI210 murine leukemia lines growing in in vivo and in vitro. Cytologia 44: 927-934.
12. Eastman, A. 1987. Cross-linking of glutaihione to DNA by cancer chemotherapeutic platinum coordination complexes. Chem. Biol. Interact. 61: 241-248.
13. _ 1991. Mechanisms of resistance to cisplatin. In: Ozols, R. F. (ed.) Molecular and Clinical Advances m Anticancer Drug Resistance. Academic Publications. Boston. pp. 233-249.
14. Fichtīnger-Schepman, A M. J., Van Dijk-Knijnenburg. H. C. M., Van der Velde-Visser, S. D., Berends, F and Raan, R. A. 1995. Cisplatin- and carboplatin-DNA adducts: is Pt-AG the cytotoxic lesion? Carcinogenesis 16, 2447-2453.
15. Giri, A. 1995. Studies on the effect of cisplatin on malignant and normal cells: preliminary investigations on cispiatin combination chemotherapy. Ph.D. Thesis, North-Eastern Hill University, Shillong. pp. 1-268.
16. _ and Prasad, S. B. 1996. Protective effect of vitamin C on cisplatin induced mutagenicity. In: Corbella, P. Corbella, J., Domingo, J. L., Etienne, J. C. and Llobet, J. M. (eds.) Metal Ions in Biology and Medicine. John Libbey Eurotext, Paris. Vol. 4, pp. 306-308.
17. Goldie, H. and Felix, M. D. 1951. Growth characteristics of free tumor cells transformed serially in the peritoneal fluid of the mouse. Cancer Res. 11: 73-80.
18. Greene, M. H. 1992. Is cisplatin a human carcinogen? J. Natl Cancer Inst. 84: 306-312.
19. Hamerton, J. L. 1970. Robertsonian translocation. In: Jacobs, P. A., Price, W. H. and Law, P. (eds.) Human Population Cytogenetics. Baltimore, pp. 63-80.
20. Jurga, L., Misurova, E., Kovac, V. and Sevcikova, I. 1994. The role of cisplatin in chemotherapy of advanced breast cancer. Neoplasma 41: 347-352.
21. Kociba, R. J., Sleight, S. D. and Rosenberg, B. 1970. Inhibition of Dunning ascitic leukemia and Walker-256 carcmosarcoma with cis-diamminedichloroplatinum (NSC-119875). Cancer Chemother. Rep. 54: 325-328.
22. Krakoff, I. H. 1979. Nephrotoxiciry of cis-dichlorodiammineplatinum. Cancer Treat. Rep. 63: 1523-1525.
23. Nakano, S. and Gemba, M. 1989. Potentialion of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Japan. J Pharmacol. 50. 87-92.
24. Pascoe, J. M. and Roberts, J. J. 1974. Interactions between mammalian cell DNA and inorganic platinum compounds. Biochem. Pharmacol. 23. 1345-1357.
25. Pera, M. F., Friedlos, F., Mills, J. and Roberts, J. J 1987. Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamm medichloroplatinum (II). Cancer Res. 47: 6810-6813.
26. Pil, P. and Lippard, S J 1997 Cisplatin and related drugs. In: Bertino, J. R. (ed ) Encyclopedia of Cancer. Academic Press, Inc. San Diego, Vol. 1, pp. 392-410
27. Pinto, A. L. and Lippard S. J. 1985. Binding of the antitumor drug cis-diamminedichloroplatinum (II) (cisplatin) to DNA. Biochim. et Biophys. Acta 780: 167-180.
28. Prasad, S. B. and Gin, A. 1994 Antitumor effect of cisplatin against murine ascites Dalton's lymphorna, Ind. J. Exp. Biol. 32: 155-162.
29. Rosenberg, B 1985. Fundamental siudics with cisplatin. Cancer 55. 2303-2316
30. Rowley, J. D 1980. Chromosome abnormalities in cancer. Cancer Genet. Cytogenet. 2: 175-198.
31. Savage, J. P. K. 1976. Classification and relationships of induced chromosomal structural changes. J. Med. Gen. 13: 103-122.
32. Sedlak, J. and Lindsay, R. H. 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissues with Ellman's reagent Anal. Biochem. 25: 192-205.
33. Sherman, S. E. and Lippard, S. J. 1987. Structural aspects of platinum anticancer drug interaction with DNA. Chem. Rev. 87: 1153-1181
34. Sodhi, A and Aggarwal, S. K. 1974. Effects of cis-dichlorodiammine platinum (II) in the regression of Sarcoma-180: a fine structural study. J. Natl. Cancer Inst. 53: 85-101.
35. Sugimoto, C., Matsukawa, S., Fujieda, S., Noda, I., Tanaka, N., Tsuzuki, H. and Saito, H. 1996. Involvement of intracellular glutathione m induction of apoptosis by cisplatin in a human pharyngeal carcinoma cell line. Anticancer Res. 16: 675-680.
36. Suzuki, C A. M and Cherian, M G 1990. The interactions of cis-diamrmnedichloroptaiinum with metallothionein and giutathione in rat liver and kidney Toxicology 64: 113-127.
37. Tandon, P. and Sodhi, A. 1985 Cis-dichlorodiammme platinum (II) induced aberrations in mouse bone-marrow chromosomes, Mutat. Res. 156. 187-193.
38. Van den Berg, H W and Roberts, J. J. 1975. Post-replication repair of DNA in Chinese hamster cells treated with cw-platinum (II) diamminedichloride Enhancement of toxicity and chromosome damage by caffeine. Mutat. Res. 33: 279-284.
39. Yarema, K. J., Wilson, J. M., Lippard S. J. and Essigmann, J. M. 1994. Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicitv of two platinum anticancer drugs. J. Med. Chem. 236: 1034-1048.
40. Zarnble, B. D. and Lippard S. J. 1995. Cisplatin and DNA repair in cancer chemotherapy Trends in Biochem. Sci. 20: 435-439
41. Zwelling, L. A., Bradley, M. O., Sharkey, N A., Anderson, T and Kohn, K W 1979 cytotoxicity and Dcviotoxicitv and DNA crosslinking in V79 Chinese hamster cells treated with cis- and transPu ll) diamminedichloride. Mutat. Res. 67: 271-280.